112 related articles for article (PubMed ID: 17316479)
21. Impact and cost-effectiveness of rotavirus vaccination in Bangladesh.
Pecenka C; Parashar U; Tate JE; Khan JAM; Groman D; Chacko S; Shamsuzzaman M; Clark A; Atherly D
Vaccine; 2017 Jul; 35(32):3982-3987. PubMed ID: 28623028
[TBL] [Abstract][Full Text] [Related]
22. Cost-effectiveness of childhood rotavirus vaccination in Taiwan.
Wu CL; Yang YC; Huang LM; Chen KT
Vaccine; 2009 Mar; 27(10):1492-9. PubMed ID: 19186200
[TBL] [Abstract][Full Text] [Related]
23. Cost-effectiveness of childhood rotavirus vaccination in Germany.
Aidelsburger P; Grabein K; Böhm K; Dietl M; Wasem J; Koch J; Ultsch B; Weidemann F; Wichmann O
Vaccine; 2014 Apr; 32(17):1964-74. PubMed ID: 24561052
[TBL] [Abstract][Full Text] [Related]
24. Cost-effectiveness of a pentavalent rotavirus vaccine in Japan.
Itzler R; O'Brien MA; Yamabe K; Abe M; Dhankhar P
J Med Econ; 2013 Oct; 16(10):1216-27. PubMed ID: 23919721
[TBL] [Abstract][Full Text] [Related]
25. Projected health impact and cost-effectiveness of rotavirus vaccination among children <5 years of age in China.
Liu N; Yen C; Fang ZY; Tate JE; Jiang B; Parashar UD; Zeng G; Duan ZJ
Vaccine; 2012 Nov; 30(48):6940-5. PubMed ID: 22705174
[TBL] [Abstract][Full Text] [Related]
26. Health care costs of diarrheal disease and estimates of the cost-effectiveness of rotavirus vaccination in Vietnam.
Fischer TK; Anh DD; Antil L; Cat ND; Kilgore PE; Thiem VD; Rheingans R; Tho le H; Glass RI; Bresee JS
J Infect Dis; 2005 Nov; 192(10):1720-6. PubMed ID: 16235169
[TBL] [Abstract][Full Text] [Related]
27. Cost-effectiveness of a pentavalent human-bovine reassortant rotavirus vaccine for children ≤5 years of age in Taiwan.
Itzler RF; Chen PY; Lac C; El Khoury AC; Cook JR
J Med Econ; 2011; 14(6):748-58. PubMed ID: 21919673
[TBL] [Abstract][Full Text] [Related]
28. Potential impact and cost-effectiveness of rotavirus vaccination in Afghanistan.
Anwari P; Debellut F; Pecenka C; Parwiz SM; Clark A; Groman D; Safi N
Vaccine; 2018 Dec; 36(51):7769-7774. PubMed ID: 29107346
[TBL] [Abstract][Full Text] [Related]
29. Cost-effectiveness of rotavirus vaccination as part of the national immunization program for Thai children.
Chotivitayatarakorn P; Chotivitayatarakorn P; Poovorawan Y
Southeast Asian J Trop Med Public Health; 2010 Jan; 41(1):114-25. PubMed ID: 20578490
[TBL] [Abstract][Full Text] [Related]
30. Cost-effectiveness of universal rotavirus vaccination in reducing rotavirus gastroenteritis in Ireland.
Tilson L; Jit M; Schmitz S; Walsh C; Garvey P; McKeown P; Barry M
Vaccine; 2011 Oct; 29(43):7463-73. PubMed ID: 21821085
[TBL] [Abstract][Full Text] [Related]
31. Health impact and cost-effectiveness of a domestically-produced rotavirus vaccine in India: A model based analysis.
Rose J; Homa L; Meropol SB; Debanne SM; Bielefeld R; Hoyen C; Singer ME
PLoS One; 2017; 12(11):e0187446. PubMed ID: 29099848
[TBL] [Abstract][Full Text] [Related]
32. The cost effectiveness of rotavirus vaccination in Iran.
Mousavi Jarrahi Y; Zahraei SM; Sadigh N; Esmaeelpoor Langeroudy K; Khodadost M; Ranjbaran M; Sanjari Moghaddam A; Besharat M; Mosavi Jarrahi A
Hum Vaccin Immunother; 2016 Mar; 12(3):794-800. PubMed ID: 26360331
[TBL] [Abstract][Full Text] [Related]
33. Comparative evaluation of the potential impact of rotavirus versus HPV vaccination in GAVI-eligible countries: a preliminary analysis focused on the relative disease burden.
Kim SY; Sweet S; Chang J; Goldie SJ
BMC Infect Dis; 2011 Jun; 11():174. PubMed ID: 21679420
[TBL] [Abstract][Full Text] [Related]
34. Costs of diarrheal disease and the cost-effectiveness of a rotavirus vaccination program in kyrgyzstan.
Flem ET; Latipov R; Nurmatov ZS; Xue Y; Kasymbekova KT; Rheingans RD
J Infect Dis; 2009 Nov; 200 Suppl 1():S195-202. PubMed ID: 19817600
[TBL] [Abstract][Full Text] [Related]
35. The cost-effectiveness of rotavirus vaccination in Armenia.
Jit M; Yuzbashyan R; Sahakyan G; Avagyan T; Mosina L
Vaccine; 2011 Nov; 29(48):9104-11. PubMed ID: 21945959
[TBL] [Abstract][Full Text] [Related]
36. Potential epidemiological and economical impact of two rotavirus vaccines in Colombia.
De la Hoz F; Alvis N; Narváez J; Cediel N; Gamboa O; Velandia M
Vaccine; 2010 May; 28(22):3856-64. PubMed ID: 20347057
[TBL] [Abstract][Full Text] [Related]
37. Estimated impact and cost-effectiveness of rotavirus vaccination in India: effects of geographic and economic disparities.
Rheingans R; Anderson JD; Anderson B; Chakraborty P; Atherly D; Pindolia D
Vaccine; 2014 Aug; 32 Suppl 1():A140-50. PubMed ID: 25091669
[TBL] [Abstract][Full Text] [Related]
38. Impact of the national rotavirus vaccination programme on acute gastroenteritis in England and associated costs averted.
Thomas SL; Walker JL; Fenty J; Atkins KE; Elliot AJ; Hughes HE; Stowe J; Ladhani S; Andrews NJ
Vaccine; 2017 Jan; 35(4):680-686. PubMed ID: 28007397
[TBL] [Abstract][Full Text] [Related]
39. Cost-effectiveness of Rotavirus vaccination in Vietnam.
Kim SY; Goldie SJ; Salomon JA
BMC Public Health; 2009 Jan; 9():29. PubMed ID: 19159483
[TBL] [Abstract][Full Text] [Related]
40. Projected cost-effectiveness of rotavirus vaccination for children in Asia.
Podewils LJ; Antil L; Hummelman E; Bresee J; Parashar UD; Rheingans R
J Infect Dis; 2005 Sep; 192 Suppl 1():S133-45. PubMed ID: 16088797
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
